1 |
Aceclofenac & Paracetamol Suspension |
Each 5ml contains:
Aceclofenac
Paracetamol
In a Flavoured SyrupyBase.
Approved colour used |
IP
IP |
100mg
250mg
q.s. |
2 |
Acetaminophen, Dextromethorphan, Guaiphenesin, Phenylephrine HCl, Chlorpheniramine Maleate & Menthol Suspension |
Each 5ml Contains :
Acetaminophen
Dextromethorphan Hydrobromide
Guaiphenesin
Phenylephrine Hydrochloride
Chlorpheniramine Maleate
Menthol
In a flavoured Suspension Base
Colour: Sunset Yellow FCF |
USP
BP
BP
BP
BP
BP |
250mg
10mg
50mg
5mg
2mg
1mg
q.s |
3 |
Albendazole & Ivermectin suspension |
Each 5 ml contains:
Albendazole
Ivermectin
Flavoured syrupybase |
IP
IP |
200 mg
1.5 mg |
4 |
Albendazole Oral Suspension IP |
Each ml Contains:
Albendazole
In flavoured Syrupybase
Approved colour used |
IP |
200 mg
q.s. |
5 |
Albendazole Oral Suspension IP |
Each 5ml contains:
Albendazole
Excipients
Approved colour used |
IP |
200mg
q.s. |
6 |
Aluminium , Magnesium & simethicone oral Suspension IP |
Each 10ml contains :
Aluminiumhydroxide Gel
Equ. to Dried Aluminium Hydroxide Gel
Magnesium Hydroxide Paste
Equ. to Magnesium Hydroxide
Simethicone
In a flavoured Palatable Base
Colour :Erythrosine & Tartrazine |
IP
IP
IP |
250mg
250mg
50mg
q.s |
7 |
Aluminium Hydroxide, Magnesium Hydroxide & Oxetacaine Oral Suspension |
Each 5 ml contains:
Aluminium Hydroxide
(Added Aluminium Hydroxide paste Eq. to dried aluminium
hydroxide gel )
Magnesium Hydroxide
(Added as magnesium Hydroxide Paste)
Oxetacaine
Flavoured palatable base |
IP
IP
IP
BP |
0.291 g
0.380 g
98 mg
10 mg
q.s. |
8 |
Azithromycin Oral Suspension IP |
Each 5 ml contains
Azithromycin Dihydrate
eq. toAnhydrousAzithromycin
In a flavoured Syrupybase.
Approved Colour Used |
IP |
200mg
q.s. |
9 |
Azithromycin Suspension IP |
Each 5 ml contain:
Azithromycin Dihydrate
Equivalent to Azithromycin Anhydrous
In flavoured Syrupybase
Approved colour used |
IP |
100 mg
q.s |
10 |
Calcitriol & Calcium Citrate Suspension |
Each 5ml contains:
Calcitriol
Calcium Citrate
Equ. To Elemental
CalciumIn a Flavoured
syrupyBase.Approved
colour used. |
IP
USP |
0.0625mcg
100mg
q.s. |
11 |
Calcium Carbonate, & Vitamin D3 Suspension |
Each 5ml Contains :
Calcium Carbonate 625mg
(Derived from Oyster Shell)
Equ. to elemental Calcium
Vitamin D3
Flavoured SyrupyBase
ApprovedColour Used |
IP
IP |
250mg
125IU
q.s. |
12 |
Calcium Carbonate, Magnesium Hydroxide, Zinc & Vitamin D3 Suspension |
Each 5ml contains:
Calcium Carbonate
Eq. toElementalCalcium
Magnesium Hydroxide
Eq. toElemental Magnesium
Zinc Gluconate
Eq. toElemental zinc
Vitamin D3
In a Flavoured syrupybase
Approved colour used |
IP
IP
USP
IP |
625 mg
250 mg
180 mg
75 mg
14 mg
2 mg
200 IU |
13 |
Calcium Carbonate, Vitamin d3 Magnesium& Zinc Suspension. |
Each 5ml contains:
Calciumcarbonate
(eq. toElemental calcium150mg)
Vitamin D3
Magnesium Hydroxide
(Eq.to Elemental magnesium)
Zinc Gluconate
Eq.to Elemental zinc
In flavored syrupybase
ApprovedColour Used |
IP
IP
IP
IP |
375mg
200IU
25mg
10.45mg
1.5mg
q.s. |
14 |
Calcium Phosphorus, Magnesium, Zinc& Vitamin D3 Suspension |
Each 10ml (2Teaspoonful) Contains:
Calcium Phosphate
Equ. To Elemental Calcium
Equ. ToElemental
PhosphorusMagnesium
Hydroxide
Equ. ToElemental
MagnesiumZinc Gluconate
Equ. ToElemental
ZincVitamin D3
In a Flavoured Palatable Base
Approved colour used. |
IP
IP
USP
IP |
300mg
150mg
75mg
4mg
400IU
q.s. |
15 |
Calcium, Vitamin D3, Vitamin B12 & Lysine Hydrochloride Suspension |
Each 5ml contains:
Calciumcarbonate
Equ. toElemental Calcium
Vitamin D3
Vitamin B12
Lysine Hydrochloride
Flavoured sorbitol base.
Approved colour used. |
IP
IP
IP
USP |
150mg
200IU
2.5mcg
25mg
q.s. |
16 |
Deflazacort Oral Suspension |
Each 5ml contain:
Deflazacort
In flavoured Syrupybase
Approved colour used |
|
6 mg
q.s. |
17 |
Dicyclomine Hydrochloride & Simethicone Suspension |
Each 5ml contains:
Dicyclomine Hydrochloride
Simethicone Emulsion USP
Eq. to Simethicone
In a flavoured syrupy base
Approved colour used. |
IP
USP |
10mg
40mg
q.s. |
18 |
Dried Aluminium Hydroxide , Magnesium Hydroxide, Simethicone & Sorbitol Oral Suspension |
Each 5ml contains :
Dried Aluminium Hydroxide Gel
Magnesium Hydroxide
Activated Simethicone
Sorbitol Solution (Non Crystallizing 70%)
In a flavoured non syrupy base.
Approved colour used |
IP
IP
IP
IP |
250mg
250mg
50mg
1.25gm
q.s. |
19 |
Dried Aluminium Hydroxide Gel , Magnesium Hydroxide Gel, Oxetacaine & Activated Dimethicone oral Suspension |
Each 5ml contains :
Dried Aluminium Hydroxide Gel
Magnesium Hydroxide Gel
Oxetacaine
Activated Dimethicone
In a Flavoured non syrupybase
Approved colour used |
IP
IP
IP
IP |
300mg
250mg
10mg
50mg
q.s. |
20 |
Dried Aluminium Hydroxide Gel, Magnesium hydroxide, Oxetacaine and Simethicone Suspension |
Each 5ml contain:
Dried Aluminium Hydroxidegel
Magnesium hydroxide
Oxetacaine
Simethicone
In a flavoured sorbitol base
Approved colour used |
IP
IP
BP
IP |
600 mg
300mg
10 mg
25 mg
q.s. |
21 |
Ferrous Ascorbate & Folic Acid Suspension |
Each 5ml contains:-
Ferrous Ascorbate
eq. toElemental Iron
Folic Acid
Excipients
In flavored syrupybase
ApprovedColour Used |
IP |
30mg
550mcg
q.s. |
22 |
Ferrous Ascorbate, Folic Acid, Methylcobalamin Suspension |
Each 5ml contains :
Methylcobalamin
Ferrous Ascorbate
Equ. toElemental Iron
Folic Acid
In a flavoured syrupyBase
Approved colour used. |
IP
IP |
500mcg
30mg
0.5mg
q.s. |
23 |
Ibuprofen & Paracetamol Suspension |
Each 5ml Contains
Ibuprofen
Paracetamol
Flavoured Palatable base
Colour : Sunset Yellow FCF |
IP
IP |
100mg
162.5mg
q.s |
24 |
Levocarnitine Oral Solution U.S.P. |
Each 5ml contains:
Levocarnitine
In a flavoured syrupy base
Approved colour used. |
I.P. |
500mg |
25 |
Levocetirizine & Montelukast Suspension |
Each 5ml Contains :
Levocetirizine Hydrochloride
Montelukast Sodium
Equ. to Montelukast
In a flavoured syrupybase.
Approved colour used |
IP
IP |
2.5mg
4mg
q.s. |
26 |
Levocloperastine Fendizoate Oral Suspension |
Each 5ml Contains :
Levocloperastine Fendizoate
Equ. To Levocloperastine
HClIn a Flavoured Syrupy Base
Approved colour used |
|
35.4mg
20mg
q.s. |
27 |
Levofloxacin & Ornidazole Oral Suspension |
Each 5ml Contains :
Levofloxacin Hemihydrate
Equ. to Levofloxacin
Ornidazole
In a flavoured SyrupyBase.
Approved colour used |
IP
IP |
125mg
125mg
q.s. |
28 |
Liquid Paraffin & Milk of Magnesia Suspension |
Each15 ml (tablespoonful
133pprox..)Contains:
Liquid Paraffin
Milk ofMagnesia
flavoured syrupy base
Approvedcolour used |
IP
IP |
3.75ml
11.25ml
q.s. |
29 |
Magaldrate & Simethicone Oral Suspension IP |
Each 5ml contains :
Magaldrate
(as anhydrous)
Simethicone
In a Flavored Syrupybase
Approved colour used. |
IP
IP |
400mg
60mg
q.s |
30 |
Magaldrate, Simethicone & Domperidone Oral Suspension |
Each 5ml contains:
Magaldrate
Simethicone
Domperidone
Sorbitol Solution (70%)
(Non-Crystallizing)
Approved colour used |
IP
IP
IP
IP |
480mg
20mg
10mg
q.s. |
31 |
Magaldrate, Simethicone & Oxetacaine Suspension |
Each 5ml contains:
Magaldrate
Simethicone
Oxetacaine
Excipients
Approved colour used |
IP
IP
BP |
480mg
20mg
10mg
q.s. |
32 |
Magaldrate, Simethicone & Oxetacaine Suspension. |
Each 5ml contains:
Magaldrate
Simethicone
Oxetacaine
Excipients
Approved colour used. |
IP
IP
BP |
540mg
50mg
10mg
q.s. |
33 |
Magaldrate& Simethicone Oral Suspension |
Each 5ml contains:
Magaldrate
Simethicone
Sorbitol Solution (70%)
(Non Crystallising)
In a flavoured sugar freeBase.
Approved Colour Used. |
IP
IP |
400mg
20mg
q.s. |
34 |
Mefenamic Acid & Paracetamol Suspension |
Each 5mlContains:-
Mefenamic Acid
Paracetamol
In flavoured Palatablebase
Approved colour used |
IP
IP |
100 mg
250 mg
q.s. |
35 |
Mefenamic Acid Oral Suspension |
Each 5ml contains:
Mefenamic Acid
In a Flavoured SyrupyBase
Approved colour used |
IP |
100mg
q.s. |
36 |
Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension |
Each 5 ml contain:
Milk of Magnesia
Liquid Paraffin
Sodium Picosulphate
Excipients
In a Flavoured Sorbitol base
Approved colour used |
IP
IP
BP |
3.75ml
1.25ml
3.33 mg
q.s. |
37 |
Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate Suspension |
Each 5ml contains:
Liquid Paraffin
Milk of Magnesia
Sodium Picosulphate
Flavoured Non SyrupyBase
Approved colour used |
IP
IP
BP |
1.25ml
3.75ml
3.33mg
q.s. |
38 |
Multivitamin Multimineral & Antioxidant suspension |
Each 5ml contains:
Cholecalciferol (as Stabilized)
Pyridoxine HCL
Niacinamide
Cyanocobalamin
Zinc (as Zinc Gluconate )
B-Carotene Dispersion 2.5%
Manganese
(as Manganese Chloride Tetrahydrate)
Molybdenum
(as Sodium Molybdate Dihydrate )
Selenium (as Sodium Selenate)
Lysine Hydrochloride
Iodine(as Potassium Iodide )
Biotin
Chromiume
(as Chromium Chloride Hexahydrate)
Inositol
Excipients
In a flavoured syrupy base
Approved colour used. |
IP
IP
IP
IP
USP
USP
BP
BP
IP
USP
USP
USP |
200IU
1mg
15mg
1mcg
3mg
38mg
0.8mg
8mcg
10mcg
30mg
50mcg
10mcg
10mcg
10mg
q.s. |
39 |
Nitazoxanide for Oral Suspension |
Composition :
Each 5ml of reconstituted suspension contains
Nitazoxanide
Excipients
Approved Colour used |
|
100mg
q.s |
40 |
Ofloxacin & Metronidazole Suspension |
Each 5ml contains :
Ofloxacin
Metronidazole Benzoate
Equ. to Metronidazole
In a Flavoured SyrupyBase
Colour : Sunset Yellow FCF |
IP
IP |
50mg
100mg
q.s |
41 |
Ofloxacin & Metronidazole Suspension |
Each 5ml contains :
Ofloxacin
Metronidazole Benzoate
Equ. to Metronidazole
Flavoured Syrupy base
Approved colour used. |
IP
IP |
50mg
120mg
q.s |
42 |
Ofloxacin & Metronidazole Suspension |
Each 5ml contains :
Ofloxacin
Metronidazole Benzoate
Equ. To Metronidazole
In a Flavoured Palatable Base
Colour: - Approved colour used. |
IP
IP |
100mg
200mg
q.s. |
43 |
Ofloxacin oral suspension IP |
Each 5ml ofsuspension contains
Ofloxacin
In a flavoured Syrupybase.
Approved Colour Used. |
IP |
100mg
q.s. |
44 |
Ofloxacin Oral Suspension IP |
Each 5 ml contains:
Ofloxacin
Excipients
Approved colour used |
IP |
50 mg |
45 |
Ofloxacin, Metronidazole Benzoate & Simethicone Suspension |
Each 5ml Contains:-
Ofloxacin
MetronidazoleBenzoate
Equivalent toMetronidazole
Simethicone
In flavoured Syrupybase
Approved colour used |
IP
IP
IP |
50 mg
120mg
10 mg
q.s. |
46 |
Paracetamol , Phenylephrine Hydrochloride &Cetirizine Dihydrochloride suspension |
Each 5ml contains:
Paracetamol
Phenylephrine Hydrochloride
Cetirizine Dihydrochloride
In a flavoured base
Approved colour used
(Banned drug 12/08/2024) |
IP
IP
IP |
250mg
2.5mg
2.5mg
q.s |
47 |
Paracetamol & Domperidone MaleateSuspension |
Each 5ml contains :
Paracetamol
Domperidone Maleate
Flavoured Palatable Base
Colour : Sunset Yellow FCF |
IP
IP |
125mg
5mg
q.s |
48 |
Paracetamol & Domperidone Suspension |
Each 5ml contains:
Paracetamol
Domperidone
In a Flavoured syrupyBase
Approved colour used |
IP
IP |
250mg
5mg
q.s. |
49 |
Paracetamol & Mefenamic Acid Suspension |
Each 5ml Contains
Paracetamol
Mefenamic Acid
In flavoured Palatable base
Approved colour used |
IP
IP |
125mg
50mg
q.s. |
50 |
Paracetamol & Phenylephrine & Chlorpheniramine maleate Suspension |
Each 5 ml contains :-
Paracetamol
Phenylephrine HCl
Chlorpheniramine maleate
In flavoured syrupyBase.
Approved Colour Used. |
IP
IP
IP
IP |
250mg
5mg
2mg
q.s. |
51 |
Paracetamol Paediatric Oral Suspension IP |
Each 5ml contains:
Paracetamol
In a Flavoured SyrupyBase.
Approved colour used |
IP |
240mg
q.s. |
52 |
Paracetamol Paediatric Oral Suspension IP |
Each 5ml contains:
Paracetamol
In a Flavoured SyrupyBase
Approved colour used |
IP |
120mg
q.s. |
53 |
Paracetamol Suspension IP |
Each 5ml Contains
Paracetamol
Excipients
Approved colour used |
IP |
125mg
q.s. |
54 |
Paracetamol Suspension IP |
Each 5ml Contains
Paracetamol
In flavoured Palatablebase
Approved colour used |
IP |
250mg
q.s. |
55 |
Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Suspension |
Each 5ml contains
Paracetamol
Chlorpheniramine Maleate
Phenylephrine Hydrochloride
Flavoured Palatable Base
Approved Colour Used. |
IP
IP
IP |
125mg
1mg
2.5mg |
56 |
Paracetamol, Dextromethorph nHBr,Cetirizine HCL, ,Phenylephrine HCL, Sodium Citrate & Menthol Suspension |
Each 5ml Contains:
Paracetamol
Dextromethorphan HBr
Cetirizine HCL
Phenylephrine HCL
Sodium Citrate
Menthol
Ina flavoured syrupy base
Approved colour use |
IP
IP
IP
IP
IP
IP |
250mg
5mg
2.5mg
5mg
25mg
1mg
q.s |
57 |
Paracetamol, Phenylephrine HCL, & Chlorpheniramine MaleateSuspension |
Each 5ml Contains:-
Paracetamol
Phenylephrine HCL
Chlorpheniramine Maleate
In flavoured Palatablebase
Approved colour used |
IP
IP
IP |
125 mg
5 mg
1 mg
q.s. |
58 |
Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension |
Each 5ml Contains:-
Paracetamol
Phenylephrine HCL
Chlorpheniramine Maleate
Sodium Citrate
Menthol
In flavoured Syrupybase
Approved colour used |
IP
IP
IP
IP
IP |
250 mg
5 mg
0.5 mg
60 mg
1 mg
q.s. |
59 |
Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension |
Each 5ml Contains:-
Paracetamol
Phenylephrine HCL
Chlorpheniramine Maleate
Sodium Citrate
Menthol
In flavoured Syrupybase
Approved colour used |
IP
IP
IP
IP
IP |
125 mg
5 mg
0.5 mg
60 mg
1 mg
q.s. |
60 |
Paracetamol, Phenylephrine Hydrochloride & Cetirizine Dihydrochloride Suspension |
Each 5ml contains:
Paracetamol
Phenylephrine Hydrochloride
Cetirizine Dihydrochloride
In a flavoured Syrupy Base.
Approved colour used.
(Banned drug 12/08/2024) |
IP
IP
IP |
125mg
5mg
2mg
q.s. |
61 |
Paracetamol, Phenylephrine Hydrochloride & Cetirizine Hydrochloride Suspension |
Each 5ml contains:
Paracetamol
Phenylephrine Hydrochloride
Cetirizine Hydrochloride
In a flavoured SyrupyBase.
Approved colour used.
(Banned drug 12/08/2024) |
IP
IP
IP |
125mg
2.5mg
2.5mg
q.s. |
62 |
Paracetamol& Dicyclomine Hydrochloride Suspension |
Each 5ml contains:
Paracetamol
Dicyclomine Hydrochloride
Flavoured Palatable Base
Colour: Sunset YellowFCF |
IP
IP |
125mg
5mg
q.s |
63 |
Posaconazole oral Suspension |
Each ml contains:
Posaconazole
Excipients
Approved Colour Used |
IP |
40mg
q.s |
64 |
Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Suspension |
Each 5ml contains :
Potassium Citrate
Magnesium Citrate
Pyridoxine Hydrochloride
In a Flavoured SyrupyBase
Approved colour used |
IP
USP
IP |
1100mg
375mg
20mg
q.s. |
65 |
Rifaximin & Metronidazole Suspension |
Each 5 ml contains:
Rifaximin
Metronidazole Benzoate
Eq. to Metronidazole
In a flavoured base
Excipients
Approved colour used. |
I.P.
I.P. |
100mg
200mg
q.s. |
66 |
Rifaximin Oral Suspension |
Each 5ml contains:
Rifaximin
Excipients
Approved Colour Used. |
|
100mg
q.s. |
67 |
Simethicone, Norfloxacin & Metronidazole Suspension |
Each 5ml contains :
Simethicone
Norfloxacin
Metronidazole Benzoate
Equ. to Metronidazole
In a flavoured SyrupyBase
Approved colour used |
IP
IP
IP |
10mg
125mg
125mg
q.s. |
68 |
Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension |
Each 5 ml contains:
Sodium Alginate
Sodium Bicarbonate
Calcium Carbonate
In a flavoured base.
Approved colour used |
IP
IP
IP |
250mg
133.5mg
80mg
q.s. |
69 |
Sucralfate & Oxetacaine Oral suspension |
Each 10ml Contains:-
Sucralfate
Oxetacaine
In palatable sorbitol Base
Approved Colour Used. |
USP
BP |
1g.
20mg.
q.s. |
70 |
Sucralfate & Oxetacaine Suspension |
Each 5ml contains:
Sucralfate
Oxetacaine
In a flavoured syrupyBase.
Approved colour used. |
USP
BP |
500mg
10mg
q.s. |
71 |
Sucralfate & Oxetacaine Suspension |
Each 10ml contains:
Sucralfate
Oxetacaine
In a flavoured palatable base
Approved colour used |
IP
BP |
1g
10 mg
q.s. |
72 |
Sucralfate & Oxetacaine Suspension |
Each 5ml contains:
Sucralfate
Oxetacaine
In a flavoured palatable base
Approved colour used |
USP
BP |
1g
10 mg
q.s. |
73 |
Sucralfateand Oxetacaine Suspension |
Each 10ml contain:
Sucralfate
Oxetacaine
In a flavoured sorbitol base
Approved colour used |
IP
BP |
IP
BP |
74 |
Ursodeoxycholic Oral Acid Suspension |
Each 5ml Contains :
Ursodeoxycholic Acid
Excipients
Approved colour used |
IP |
250mg
q.s. |
75 |
ZincGluconate Suspension |
Each 5ml contains:
Zinc Gluconate
Equ. to Elemental Zinc
In a flavoured SyrupyBase
Colour: Ponceau 4R |
USP |
20mg
q.s |